Impact of new dialysis solutions on peritonitis rates.

Ahmad, S; Sehmi, J S; Ahmad-Zakhi, K H; Clemenger, M; Levy, J B; Brown, E A

Ahmad, S; Sehmi, J S; Ahmad-Zakhi, K H; Clemenger, M; Levy, J B; Brown, E A.

Affiliation

Ahmad S; Department of Renal Medicine, Imperial College London, Charing Cross Hospital, London, UK. sohail.ahmad@imperial.ac.uk

Kidney Int Suppl ; (103): S63-6, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17080113

Subject(s)

Dialysis Solutions/administration & dosage; Kidney Failure, Chronic/therapy; Peritoneal Dialysis/methods; Peritonitis/prevention & control; Bicarbonates/administration & dosage; Bicarbonates/adverse effects; Dialysis Solutions/adverse effects; Humans; Lactic Acid/administration & dosage; Lactic Acid/adverse effects; Peritonitis/etiology; Prospective Studies; Secondary Prevention; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peritonitis / Dialysis Solutions / Peritoneal Dialysis / Kidney Failure, Chronic Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Humans Language: En Journal: Kidney Int Suppl Year: 2006 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links